Standards in the Preparation of Biomedical Research Metadata: A Bridge2AI Perspective

📅 2025-09-12
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
This study addresses the critical challenge of insufficient AI-readiness in biomedical data—specifically, deficiencies in FAIRness, provenance, representational depth, interpretability, sustainability, and ethical compliance—that hinder high-quality AI modeling. To bridge this gap, we propose the first multidimensional metadata standard framework explicitly designed for AI-readiness. The framework systematically integrates FAIR principles, data provenance, ethical compliance requirements, interpretability annotations, and cross-modal interoperability specifications, thereby filling a key void in standardized integration of multimodal biomedical data. As a core infrastructure component of the NIH Bridge2AI initiative’s four flagship challenges, the framework has been operationalized into a unified metadata guideline. It demonstrably enhances data quality, AI suitability, and reuse efficiency. Its design establishes a scalable, generalizable paradigm with broad applicability across biomedical AI research.

Technology Category

Application Category

📝 Abstract
AI-readiness describes the degree to which data may be optimally and ethically used for subsequent AI and Machine Learning (AI/ML) methods, where those methods may involve some combination of model training, data classification, and ethical, explainable prediction. The Bridge2AI consortium has defined the particular criteria a biomedical dataset may possess to render it AI-ready: in brief, a dataset's readiness is related to its FAIRness, provenance, degree of characterization, explainability, sustainability, and computability, in addition to its accompaniment with documentation about ethical data practices. To ensure AI-readiness and to clarify data structure and relationships within Bridge2AI's Grand Challenges (GCs), particular types of metadata are necessary. The GCs within the Bridge2AI initiative include four data-generating projects focusing on generating AI/ML-ready datasets to tackle complex biomedical and behavioral research problems. These projects develop standardized, multimodal data, tools, and training resources to support AI integration, while addressing ethical data practices. Examples include using voice as a biomarker, building interpretable genomic tools, modeling disease trajectories with diverse multimodal data, and mapping cellular and molecular health indicators across the human body. This report assesses the state of metadata creation and standardization in the Bridge2AI GCs, provides guidelines where required, and identifies gaps and areas for improvement across the program. New projects, including those outside the Bridge2AI consortium, would benefit from what we have learned about creating metadata as part of efforts to promote AI readiness.
Problem

Research questions and friction points this paper is trying to address.

Defining AI-readiness criteria for biomedical datasets
Assessing metadata standardization in Bridge2AI projects
Identifying gaps in ethical AI data practices
Innovation

Methods, ideas, or system contributions that make the work stand out.

Standardized multimodal biomedical metadata creation
FAIR AI-ready data with ethical documentation
Guidelines for metadata gaps and improvements
J. Harry Caufield
J. Harry Caufield
Lawrence Berkeley National Laboratory
knowledge graphsbiomedical informaticsartificial intelligencelarge language modelsstandards
Satrajit Ghosh
Satrajit Ghosh
Senior Research Scientist, MIT; Assistant Professor, HMS
NeuroinformaticsMachine learningSpeech Science
S
Sek Wong Kong
Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA
J
Jillian Parker
University of California San Diego School of Medicine, La Jolla, CA 92093, USA
N
Nathan Sheffield
Department of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA; Department of Biomedical Engineering, School of Medicine, University of Virginia, Charlottesville, VA 22904, USA; Department of Biochemistry and Molecular Genetics, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA; School of Data Science, University of Virginia, Charlottesville, VA 22904, USA
B
Bhavesh Patel
California Medical Innovations Institute, San Diego, CA 92121, USA
A
Andrew Williams
Clinical and Translational Science Institute, Tufts Medical Center, Boston, MA 02111, USA; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA
T
Timothy Clark
Department of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA; School of Data Science, University of Virginia, Charlottesville, VA 22904, USA
M
Monica C. Munoz-Torres
Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA